Icon
+91 94997 68112
Login Register

RAZADYNE (nda021169)- (EQ 4MG BASE,EQ 8MG BASE,EQ 12MG BASE)

GALANTAMINE HYDROBROMIDE JANSSEN PHARMS
EQ 4MG BASE,EQ 8MG BASE,EQ 12MG BASE
Yes No
2017-Jun-06 Expired
None None
None No
RAZADYNE® is a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type
6 3 3
Total Other Developers 1
Drugs with Suitability No
EQ 4MG BASE ** ** - - 2
EQ 8MG BASE ** ** - - 2
EQ 12MG BASE ** ** - - 2
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ***** ***** ************** **., ***. ******* *********** ** ******** **** *** ******, ***, *******, ******, ***** (***) ***
****** ***** ***** *** ***************, ***. ******* ***** *********** *-*, ******* *** **., ******* ****, ******, ****** (***) ***
****** ***** ****** *** *** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.